Greencamp

FEBRUARY 17, 2019

One study from 2004 looked at cannabinoids as a treatment option for managing bowel diseases symptoms (including IBS), because of their anti-inflammatory properties, but also the ability to diminish pain levels. Cannabis (more precisely its compound CBD), is a proven anti-inflammatory agent. ( How to choose the best strain for IBS?

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Greencamp

AUGUST 16, 2018

Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Greencamp

FEBRUARY 2, 2019

Even though scientific data is still somewhat scarce on this topic, several studies confirm that cannabis directly acts on the cells of the immune system affected by HIV. It will be the biggest and most comprehensive research on this topic to date, and it will include 400 HIV patients from Florida. 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

The Cannigma

JANUARY 13, 2023

Edibles won’t produce the same experience, but topicals may be able to help, too. 4 A 2004 study found that the endocannabinoid anandamide can inhibit trigeminal neurons, which suggests a way in which endocannabinoids may be able to prevent migraines. Topical cannabis products can also be useful, but research and data is very limited.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. September 2004. 30 (2): 187–96.(1998).

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73